| Molecular formula | C204H301N51O64 |
|---|
| Molecular weight | 4492 g/mol |
|---|
| Registered trials | 61 |
|---|
| PubChem CID | 16130199 |
|---|
What Enfuvirtide Is
Enfuvirtide is a large synthetic peptide with the molecular formula C204H301N51O64 and a molecular weight of about 4,492 daltons (PubChem CID 16130199). No approved drug label is associated with this record, so the information here reflects research and trial registry data only, not an authorized indication or use.
Trial Footprint
Enfuvirtide has been studied in 61 registered clinical trials. Sample studies in the registry include a trial examining early intensification of antiretroviral therapy that included enfuvirtide in people with HIV-1 related progressive multifocal leucoencephalopathy, a study comparing an optimized background antiretroviral regimen combined with enfuvirtide in treatment-experienced participants with HIV-1 infection, and a trial comparing three doses of enfuvirtide (T-20) given alongside other antiretroviral agents in HIV-infected adults. These entries describe study design and status in the registry and do not establish safety or effectiveness.
FAQ
Based on the data available here, enfuvirtide is classified as unapproved for research purposes, and no approved drug label is associated with this record. Any use outside a registered clinical trial would fall outside authorized medical practice.
Enfuvirtide is a large synthetic peptide with the molecular formula C204H301N51O64 and a molecular weight of roughly 4,492 daltons. It is identified in PubChem under CID 16130199.
The registry lists 61 clinical trials involving enfuvirtide. These trials span different study designs and have been conducted primarily in HIV-related research contexts.
Sample trials in the registry have examined enfuvirtide in combination with antiretroviral regimens for people with HIV-1 infection, including studies in treatment-experienced participants and in a specific neurological complication of HIV. These studies are registered as completed but their results are not summarized in this record.
No adverse event report data was available in this record to summarize. Readers should consult clinical trial results or other authoritative sources for safety information.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03